You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ATO

Showing 1 - 25 of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Metastatic Colorectal Cancer Trial in Almaty (D-isoascorbic Acid (D-VC) With Arsenic Trioxide (ATO),

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • D-isoascorbic Acid (D-VC) With Arsenic Trioxide (ATO)
  • FOLFOX/FOLFIRI regimen
  • Almaty, Kazakhstan
    Kazakh Institute of Oncology and Radiology
Feb 8, 2023

Obstructive Sleep Apnea, Down Syndrome Trial in Tucson (Atomoxetine and Oxybutynin (ato-oxy))

Not yet recruiting
  • Obstructive Sleep Apnea
  • Down Syndrome
  • Atomoxetine and Oxybutynin (ato-oxy)
  • Tucson, Arizona
    University of Arizona
Jun 26, 2023

Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Birmingham, Alabama
  • +4 more
Jul 12, 2022

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Recruiting
  • Promyelocytic Leukemia, Adult Acute
  • Evaluation of first line treatment with ATO/ATRA outcome
  • Caba, Argentina
  • +1 more
Nov 9, 2021

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

Recruiting
  • Promyelocytic Leukemia
  • Arsenic trioxide
  • all-trans retinoic acid
  • Monterrey, Nuevo Leon, Mexico
    Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

Obstructive Sleep Apnea, Down Syndrome Trial in Tucson (Atomoxetine and oxybutynin (ato-oxy))

Recruiting
  • Obstructive Sleep Apnea
  • Down Syndrome
  • Atomoxetine and oxybutynin (ato-oxy)
  • Tucson, Arizona
    University of Arizona
Sep 27, 2021

Acute Myeloid Leukemia Trial in Xi'an (All-trans retinoic acid, Arsenic Trioxide, Realgar-Indigo naturalis formula)

Recruiting
  • Acute Myeloid Leukemia
  • All-trans retinoic acid
  • +2 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Mar 23, 2022

Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Realgar-Indigo naturalis formula
  • +3 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021

Neuroblastoma Trial in Guangzhou (Arsenic Trioxide)

Recruiting
  • Neuroblastoma
  • Arsenic Trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 29, 2021

AML Trial in Tianjin (Cytarabine, all-trans retinoic acid, Arsenic Trioxide)

Recruiting
  • AML
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 19, 2020

Lung Cancer, Cancer of Lung, Pulmonary Cancer Trial in Atlanta (Arsenic Trioxide)

Completed
Has Results
  • Lung Cancer
  • +4 more
  • Arsenic Trioxide
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Feb 15, 2021

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO

Active, not recruiting
  • Acute Promyelocytic Leukemia
  • QoL questionnaires
  • Ascoli Piceno, Italy
  • +15 more
Feb 3, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Philadelphia, Houston (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
  • +1 more
May 18, 2021

Arsenic Trioxide, Childhood ALL Trial in Guangzhou (Realgar Indigo naturalis formula, Conventional chemo)

Recruiting
  • Arsenic Trioxide
  • Childhood ALL
  • Realgar Indigo naturalis formula
  • Conventional chemotherapy
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jan 10, 2023

Myeloma Trial in Houston (Trisenox (Arsenic Trioxide), Velcade (Bortezomib), Melphalan)

Completed
Has Results
  • Myeloma
  • Trisenox (Arsenic Trioxide)
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Leukemia, MDS Trial in Los Angeles (arsenic trioxide, azacitidine)

Terminated
  • Leukemia
  • Myelodysplastic Syndromes
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020

Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Brussels, Belgium
  • +30 more
Aug 9, 2022

Attention Deficit/Hyperactivity Disorder Medications in Japan

Completed
  • Attention Deficit Disorder With Hyperactivity
  • MPH (Concerta)
  • +3 more
  • Titusville, New Jersey
    Janssen Investigative Site
Jan 21, 2020

Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk

Recruiting
  • Acute Promyelocytic Leukemia
  • Arsenic Trioxide
  • Alessandria, Italy
  • +27 more
Dec 31, 2021

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Cleveland (ascorbic acid, arsenic trioxide, dexamethasone)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • ascorbic acid
  • +3 more
  • Cleveland, Ohio
  • +1 more
Jul 23, 2020

Atherosclerotic Cardiovascular Disease Trial (Atozet 10/40 mg or 10/80 mg, Lipitor 40 mg or 80 mg)

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Atozet 10/40 mg or 10/80 mg
  • Lipitor 40 mg or 80 mg
  • (no location specified)
Mar 8, 2023

Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia Trial in Aurora (Cyclophosphamide)

Completed
  • Acute Myeloid Leukemia
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Aurora, Colorado
    University of Colorado Denver
Apr 28, 2021

OSA Trial in Boston (Atomoxetine 80 mg plus Oxybutynin 5 mg, Atomoxetine 80 MG, Placebo)

Not yet recruiting
  • OSA
  • Atomoxetine 80 mg plus Oxybutynin 5 mg
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens Hospital
Jul 14, 2023